Sugentech Net Income vs. Total Debt
| 253840 Stock | KRW 5,030 140.00 2.71% |
For Sugentech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sugentech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Sugentech utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Sugentech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Sugentech over time as well as its relative position and ranking within its peers.
Sugentech |
Sugentech Total Debt vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Sugentech's current stock value. Our valuation model uses many indicators to compare Sugentech value to that of its competitors to determine the firm's financial worth. Sugentech is rated second in net income category among its peers. It is rated third in total debt category among its peers making up about 0.02 of Total Debt per Net Income. The ratio of Net Income to Total Debt for Sugentech is roughly 53.94 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sugentech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sugentech's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Sugentech Total Debt vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Sugentech |
| = | 36.15 B |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Sugentech |
| = | 670.21 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Sugentech Total Debt vs Competition
Sugentech is rated third in total debt category among its peers. Total debt of Health Care Equipment & Supplies industry is presently estimated at about 49.79 Billion. Sugentech claims roughly 670.21 Million in total debt contributing just under 2% to equities under Health Care Equipment & Supplies industry.
Sugentech Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Sugentech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Sugentech will eventually generate negative long term returns. The profitability progress is the general direction of Sugentech's change in net profit over the period of time. It can combine multiple indicators of Sugentech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. Sugentech Inc. was founded in 2011 and is headquartered in Daejeon, South Korea. Sugentech is traded on Korean Securities Dealers Automated Quotations in South Korea.
Sugentech Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Sugentech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Sugentech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Sugentech's important profitability drivers and their relationship over time.
Use Sugentech in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sugentech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sugentech will appreciate offsetting losses from the drop in the long position's value.Sugentech Pair Trading
Sugentech Pair Trading Analysis
The ability to find closely correlated positions to Sugentech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sugentech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sugentech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sugentech to buy it.
The correlation of Sugentech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sugentech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sugentech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sugentech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Sugentech position
In addition to having Sugentech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Biotech Thematic Idea Now
Biotech
Companies specialized in biotechnology production and delivery of pharmaceuticals services. The Biotech theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Biotech Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Sugentech Stock
To fully project Sugentech's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Sugentech at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Sugentech's income statement, its balance sheet, and the statement of cash flows.